NCT01511523View on ClinicalTrials.gov

Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)

NAUnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Non Alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

RGMA001

3 capsules administered BID once a day.

DIETARY_SUPPLEMENT

Sugar Pill

Placebo

Trial Locations (1)

28304

Cumberland Research Associates, LLC, Fayetteville

Sponsors
All Listed Sponsors
lead

Biovil Research Group, LLC

INDUSTRY

NCT01511523 - Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD) | Biotech Hunter | Biotech Hunter